Multi-drug resistant Salmonella bacteria continue to spread across Europe, show the latest data on resistance in bacteria in humans, food and animals issued by ECDC and EFSA. There’s evidence of resistance to the antimicrobial colistin in Salmonella among poultry in the EU - this last-resort drug may soon no longer be effective for treating severe human infections with Salmonella.
ECDC encourages adoption of EU and ISO quality standards for diagnostic and reference laboratory services by its partners in EU laboratory networks and in line with national arrangements and regulations.
In principle, everyone may be at risk for contracting foodborne, waterborne or zoonotic disease although some people are more at risk than others depending on pathogen-host interactions.
This workshop on AMR in Salmonella and Campylobacter was arranged in cooperation with the FWD Network and the EU reference laboratory for antimicrobial resistance network.
Emerging diseases and outbreak investigations, whole genome sequencing-based surveillance and public health risks related to animal and food imports to the EU/EEA were some of the topics under discussion during the Food- and Waterborne Diseases and Zoonoses Network meeting.
The European Parliament Committee on the Environment, Public Health and Food Safety held a meeting with the European Commission, ECDC and EFSA on the risks posed by food-borne Campylobacter bacteria and the possible control options.
Location:Brussels, Belgium
Organized by:European Parliament Committee on the Environment, Public Health and Food Safety